Examination of Diagnostic Accuracy of UroVysion Fluorescence In Situ Hybridization for Bladder Cancer in a Single Community of Japanese Hospital Patients

OBJECTIVE: UroVysion (Abbott Molecular, Inc., Illinois, USA) is based on multicolor fluorescence in situ hybridization (FISH). It has been used successfully in the USA following its Food and Drug Administration approval in 2001. However, the technology was not approved for use in Japan until 2017. C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Asian Pac J Cancer Prev
Main Authors: Nagai, Takashi, Okamura, Takehiko, Yanase, Takahiro, Chaya, Ryosuke, Moritoki, Yoshinobu, Kobayashi, Daichi, Akita, Hidetoshi, Yasui, Takahiro
Formato: Artigo
Idioma:Inglês
Publicado em: West Asia Organization for Cancer Prevention 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6948889/
https://ncbi.nlm.nih.gov/pubmed/31030505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2019.20.4.1271
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados